Publications
N'Goran E.K, Odiere M.R, Assandé Aka R, Ouattara M, Aka N.A.D, Ogutu B, Rawago F, Bagchus W.M, Bödding M, Kourany-Lefoll E, Tappert A, Yin X, Bezuidenhout D, Badenhorst H, Huber E, Dälken B, Haj-Ali Saflo O. Efficacy, safety, and palatability of arpraziquantel (L-praziquantel) orodispersible tablets in children aged 3 months to 6 years infected with Schistosoma in Côte d'Ivoire and Kenya: an open-label, partly randomised, phase 3 trial. Lancet Infect Dis. 2023;23(7):867-876. DOI: 10.1016/S1473-3099(23)00048-8
Mahende M.K, Huber E, Kourany-Lefoll E, Ali A, Hayward B, Bezuidenhout D, Bagchus W, Kabanywanyi A.M. Comparative palatability of orally disintegrating tablets (ODTs) of praziquantel (L-PZQ and Rac-PZQ) versus current PZQ tablet in African children: a randomized, single-blind, crossover study. PLoS Negl Trop Dis. 2021;15(6):e0007370. DOI: 10.1371/journal.pntd.0007370
N'Goran E, David Aka N.A, Ouattara M, Huber E, Bezuidenhout D, Kourany-Lefoll E, Pediatric Praziquantel Consortium. Challenges and lessons from conducting a paediatric clinical trial in sub-Saharan Africa: the case of the praziquantel oral dispersible tablets phase II study in Côte d'Ivoire. Adv Parasitol. 2019;103:75-89. DOI: 10.1016/bs.apar.2018.09.002
Steiner-Monard V, Kamaka K, Karoui O, Roethlisberger S, Audran R, Daubenberger C, Fayet-Mello A, Erdmann-Voisin A, Felger I, Geiger K, Govender L, Houard S, Huber E, Mayor C, Mkindi C, Portevin D, Rusch S, Schmidlin S, Tiendrebeogo R.W, Theisen M, Thierry A.C, Vallotton L, Corradin G, Leroy O, Abdulla S, Shekalaghe S, Genton B, Spertini F, Jongo S.A. The candidate blood-stage malaria vaccine P27A induces a robust humoral response in a fast track to the field phase I trial in exposed and non exposed volunteers. Clin Infect Dis. 2019;68(3):466-474. DOI: 10.1093/cid/ciy514
Huber E, Skopp S, Kojima H, De Oliveria D.L, Kabanywanyi A.M. A bitter pill to swallow? How taste masking and assessment of praziquantel can contribute to the treatment of schistosomiasis in pre-school children. Trop Med Int Health, 2015;20(Suppl. 1):229-230
Conference Paper
Shekalaghe S, Rutaihwa M, Billingsley P.F, Chemba M, Daubenberger C.A, James E, Mpina M, Ali Juma O, Schindler T, Huber E, Gunasekera A, Manoj A, Simon B, Savarino E, Church L.W, Hermsen C.C, Sauerwein R.W, Plowe C.V, Venkatesan M, Sasi P, Lweno O, Mutani P, Hamad A, Mohammed A, Urassa A, Mzee T, Padilla D, Ruben A, Lee Sim B.K, Tanner M, Abdullah S, Hoffman S.L. Controlled human malaria infection of Tanzanians by intradermal injection of aseptic, purified, cryopreserved Plasmodium falciparum sporozoites. Am J Trop Med Hyg. 2014;91(3):471-480. DOI: 10.4269/ajtmh.14-0119
Schwiter K, Wehner N, Maihofer A, Huber E. Zur Hartnäckigkeit geschlechtssegregierter Ausbildungs- und Berufsverläufe: konzeptionelle Überlegungen zu einer empirischen Untersuchung. Femina Politica. 2011;14(2):20-32
Journal Article
Crameri A, Marfurt J, Mugittu K, Maire N, Regos A, Coppee J.Y, Sismeiro O, Burki R, Huber E, Laubscher D, Puijalon O, Genton B, Felger I, Beck H.P. Rapid microarray-based method for monitoring of all currently known single-nucleotide polymorphisms associated with parasite resistance to antimalaria drugs. J Clin Microbiol. 2007;45(11):3685-3691